Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Digital Depression Intervention May Improve Symptoms
Clinical Breakthroughs

Digital Depression Intervention May Improve Symptoms

By Melissa RohmanMay 25, 2021
Share
Facebook Twitter Email
David Mohr, PhD, professor of Preventive Medicine in the Division of Behavioral Medicine, of Medical Social Sciences, of Psychiatry and Behavioral Sciences, was a co-author of the study published in JAMA.

A mental health smartphone app developed by a team of Northwestern Medicine investigators helped improve depressive symptoms in patients in Brazil and Peru with diabetes and hypertension, according to a recent clinical trial published in JAMA.

The findings suggest that using such digital mental health interventions may help treat depressive symptoms more effectively than standard care alone, as well as address treatment gaps in low- and middle-income countries where mental health care is currently lacking.

“This is not just giving people an app, it is giving people tools for self-management and is also connecting people with a human inside the care system and that’s important,” said David Mohr, PhD, professor of Preventive Medicine in the Division of Behavioral Medicine, of Medical Social Sciences, of Psychiatry and Behavioral Sciences and a co-author of the study.

Depression is a leading contributor to disease burden globally, especially in low- and middle-income countries, and has been commonly associated with the development of diabetes and cardiovascular disease.

“Depression can increase a lot of unhealthy behaviors, such as increasing smoking, unhealthy eating, or decreasing physical activity, which can impact diabetes and cardiovascular disease. Depression affects immune and endocrine function in ways that can have adverse effects on disease processes, so there are  potentially both direct as well as indirect pathways through behavior,” said Mohr, who is also director of the Center for Behavioral Intervention Technologies and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

While the use of digital mental health interventions has increased over time, their effectiveness in reducing depressive symptoms in this patient population has remained understudied.

For the current clinical trial, the investigators provided a mental health smarphone app called CONEMO to patients with hypertension and diabetes in Sao Paulo, Brazil and Lima, Peru. The app was developed by a team led by Mohr in collaboration, with input from patients and nurses in Brazil and Peru. The app’s design is based on the principles of behavioral activation, a common behavior therapy framework for treating depression. The app connected patients to a team of healthcare providers in their respective countries through the app’s main dashboard. The app’s platform is also multilingual, providing support to patients and management tools to nurses in both Spanish and Portuguese.

Patients were randomized to receive standard care or CONEMO via a provided smartphone for six weeks. In both countries, almost half of patients were between the ages of 41 and 60 years old and more than 85 percent were women. Additionally, 62 percent of patients in Brazil and 35 percent of patients in Peru had fewer than nine years of education.

After three-month follow-up period, the investigators found that more patients in both countries who used CONEMO saw a 50 percent decrease in their PHQ-9 score and overall depressive symptoms from baseline, compared to patients who received standard care alone.

After six months, however, the difference between groups was not significant, prompting the investigators to extend the treatment and follow-up period after the app is delivered for future trials.

“Six weeks of treatment for depression is not long. For many people, depression is a chronic relapsing, remitting disorder, and they need a longer-term follow-up,” Mohr said.

This work was supported by the National Institute of Mental Health grant U19MH098780.

Global Health Medical Social Sciences Preventive Medicine Psychiatry Research
Share. Facebook Twitter Email

Related Posts

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

Comments are closed.

Latest News

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

New Directions for HIV Treatment

Mar 21, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230317_NM651
20230317_NM610
20230317_NM569
20230317_NM537
20230317_NM331
20230317_NM323
20230317_NM316
20230317_NM336
20230317_NM626
20230317_NM662
20230317_NM655
20230317_NM642

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.